Skip to main content
. Author manuscript; available in PMC: 2021 Jun 16.
Published in final edited form as: Anal Chem. 2020 Jun 2;92(12):8201–8208. doi: 10.1021/acs.analchem.0c00420

Figure 3.

Figure 3.

(A) PRM quantification of glycopeptide LGnATAIF_54200 2+ (top) and LGnATAIF_54200 3+ (bottom). (B) MS1 spectrum of parent ions with two charge states (top), and MS2 spectrum of charge 2+ state (bottom). (C) Relative abundance of glycopeptide LGnATAIF_54200 2+/3+ in cirrhosis and HCC patients. (D) ROC analysis of LGnATAIF_54200 2+/3+ in patients.